Drug Markets/EMTRICITABINE, RILPIVIRINE, TENOFOVIR DISOPROXIL FUMARATE

EMTRICITABINE, RILPIVIRINE, TENOFOVIR DISOPROXIL FUMARATE

1 NDCs across 1 manufacturers|1 Generic,0 Brand

Total NDCs

1G / 0B

Manufacturers

competing in market

Price Spread

$114.99 – $114.99

7d Activity

4↑-3 flat

of 1 total NDCs

Monthly average NADAC price per unit, split by generic and brand

1 manufacturer producing EMTRICITABINE, RILPIVIRINE, TENOFOVIR DISOPROXIL FUMARATE

1 NDCs total, 1 shown

Drug ↕	NDC	Manufacturer ↕	Price	Market Outlier	Class	7d Change ↕	Therapeutic Class
EMTRICITABINE-RILPIVIRINE-TENOFOVIR DIS FUM 200-25-300 MG TB	00378544093	Mylan Pharmaceuticals Inc.	$114.9924 per EA	—	Generic	+0.12%	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor